Metabolic syndrome and risk of gastrointestinal cancers: an investigation using large-scale molecular data

Gastrointestinal cancer risk is influenced by the presence of metabolic syndrome [MetS]. However, previous epidemiological studies lacked full serological biomarker data for the classification of MetS and the interaction of MetS with germline cancer risk variants is unknown.

Source: Clinical Gastroenterology and Hepatology - October 19, 2021 Category: Gastroenterology Authors: Joseph A. Rothwell, Mazda Jenab, Mojgan Karimi, Th érèse Truong, Yahya Mahamat-Saleh, Pietro Ferrari, S. Ghazaleh Dashti, Tilman Kühn, Amanda J. Cross, Gianluca Severi, Marc J. Gunter, Neil Murphy Source Type: research